Search
Entrada Therapeutics Inc
TRDAAdd to Watchlist
6.015USD
-0.035-0.59%
Market hours （ET）Quotes delayed by 15 min
228.21MMarket Cap
LossP/E TTM
Shareholding Stats
Updated: Thu, May 14
Updated: Thu, May 14
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Baker Bros. Advisors LP
13.07%
MPM Capital Inc.
11.29%
5AM Ventures
10.45%
F. Hoffman La Roche, Ltd.
6.62%
TCG Crossover Management, LLC
5.38%
Other
53.20%
Shareholders
Shareholders
Proportion
Baker Bros. Advisors LP
13.07%
MPM Capital Inc.
11.29%
5AM Ventures
10.45%
F. Hoffman La Roche, Ltd.
6.62%
TCG Crossover Management, LLC
5.38%
Other
53.20%
Shareholder Types
Shareholders
Proportion
Investment Advisor/Hedge Fund
22.66%
Investment Advisor
20.02%
Hedge Fund
18.84%
Corporation
11.10%
Venture Capital
10.88%
Private Equity
1.96%
Research Firm
1.78%
Individual Investor
1.21%
Pension Fund
0.19%
Other
11.36%
Institutional Shareholding
Updated: Wed, Apr 1
Updated: Wed, Apr 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2026Q1
267
31.31M
80.65%
-1.50M
2025Q4
247
29.95M
78.37%
-1.24M
2025Q3
229
29.67M
77.64%
-2.01M
2025Q2
226
35.35M
92.97%
-1.79M
2025Q1
237
37.05M
97.63%
-2.01M
2024Q4
222
37.20M
98.96%
+761.72K
2024Q3
209
35.09M
95.11%
-779.91K
2024Q2
193
34.68M
94.55%
+2.42M
2024Q1
185
31.33M
93.34%
-1.07M
2023Q4
174
31.30M
93.83%
-1.07M
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Baker Bros. Advisors LP
5.07M
13.25%
+28.87K
+0.57%
Dec 31, 2025
MPM Capital Inc.
4.38M
11.44%
--
--
Sep 30, 2025
5AM Ventures
4.06M
10.6%
--
--
Dec 31, 2025
F. Hoffman La Roche, Ltd.
2.57M
6.71%
-175.00K
-6.38%
Dec 31, 2024
TCG Crossover Management, LLC
2.09M
5.46%
+171.05K
+8.92%
Dec 31, 2025
BlackRock Institutional Trust Company, N.A.
1.87M
4.88%
+85.92K
+4.82%
Dec 31, 2025
Merck & Co Inc
1.74M
4.54%
--
--
Dec 31, 2025
Wellington Management Company, LLP
1.04M
2.73%
+90.34K
+9.47%
Dec 31, 2025
StepStone Group LP
761.28K
1.99%
--
--
Dec 31, 2025
View more
Related ETFs
Updated: Tue, Dec 2
Updated: Tue, Dec 2
Name
Proportion
Virtus LifeSci Biotech Clinical Trials ETF
0.6%
iShares Neuroscience and Healthcare ETF
0.26%
iShares Micro-Cap ETF
0.04%
WisdomTree US SmallCap Fund
0.03%
Invesco Nasdaq Biotechnology ETF
0.03%
ProShares Ultra Nasdaq Biotechnology
0.03%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
0.03%
Avantis US Small Cap Equity ETF
0.02%
iShares Biotechnology ETF
0.01%
iShares Russell 2000 ETF
0.01%
View more
Virtus LifeSci Biotech Clinical Trials ETF
Proportion0.6%
iShares Neuroscience and Healthcare ETF
Proportion0.26%
iShares Micro-Cap ETF
Proportion0.04%
WisdomTree US SmallCap Fund
Proportion0.03%
Invesco Nasdaq Biotechnology ETF
Proportion0.03%
ProShares Ultra Nasdaq Biotechnology
Proportion0.03%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
Proportion0.03%
Avantis US Small Cap Equity ETF
Proportion0.02%
iShares Biotechnology ETF
Proportion0.01%
iShares Russell 2000 ETF
Proportion0.01%